Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Burger

Showing results (261-270 of 305) with videos related to

Pageof 31
Sort By:
Plos One|February 2, 2012
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancerPaul H van der Horst, Yongyi Wang, Ingrid Vandenput, et al.
Fertility and Sterility|July 11, 2006
Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagenAnet H A Klaassens, F Heidy van Wijk, Payman Hanifi-Moghaddam, et al.
Reproductive Biomedicine Online|September 30, 2006
Optimum number of oocytes for a successful first IVF treatment cycleM H van der Gaast, M J C Eijkemans, J B van der Net, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2002
Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancerE E Hanekamp, E C M Kühne, E Smid-Koopman, et al.
International Journal of Cancer|May 24, 2008
Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cellsLindy A M Santegoets, Manon van Seters, Claudia Heijmans-Antonissen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 15, 2007
Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathwaySussane C J P Gielen, Lindy A M Santegoets, Liesbeth C M Kühne, et al.
International Journal of Cancer|January 30, 2014
A mouse model for endometrioid ovarian cancer arising from the distal oviductPaul H van der Horst, Marten van der Zee, Claudia Heijmans-Antonissen, et al.
Journal of Lower Genital Tract Disease|May 6, 2024
Outcome Measures in Adult Vulvar Lichen Sclerosus: A Case Series of Women Diagnosed as JuvenilesBeth Morrel, Marianne J Ten Kate-Booij, Charlotte van Dijk, et al.
Cancer|November 21, 2012
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counselingPeggy M L H Vencken, Mieke Kriege, Maartje Hooning, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Progestogenic effects of tibolone on human endometrial cancer cellsL J Blok, P E De Ruiter, E C M Kühne, et al.
Pageof 31

Showing results (261-270 of 305) with videos related to

Sort By:
Pageof 31
Plos One|February 2, 2012
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancerPaul H van der Horst, Yongyi Wang, Ingrid Vandenput, et al.
Fertility and Sterility|July 11, 2006
Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagenAnet H A Klaassens, F Heidy van Wijk, Payman Hanifi-Moghaddam, et al.
Reproductive Biomedicine Online|September 30, 2006
Optimum number of oocytes for a successful first IVF treatment cycleM H van der Gaast, M J C Eijkemans, J B van der Net, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2002
Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancerE E Hanekamp, E C M Kühne, E Smid-Koopman, et al.
International Journal of Cancer|May 24, 2008
Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cellsLindy A M Santegoets, Manon van Seters, Claudia Heijmans-Antonissen, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|November 15, 2007
Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathwaySussane C J P Gielen, Lindy A M Santegoets, Liesbeth C M Kühne, et al.
International Journal of Cancer|January 30, 2014
A mouse model for endometrioid ovarian cancer arising from the distal oviductPaul H van der Horst, Marten van der Zee, Claudia Heijmans-Antonissen, et al.
Journal of Lower Genital Tract Disease|May 6, 2024
Outcome Measures in Adult Vulvar Lichen Sclerosus: A Case Series of Women Diagnosed as JuvenilesBeth Morrel, Marianne J Ten Kate-Booij, Charlotte van Dijk, et al.
Cancer|November 21, 2012
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counselingPeggy M L H Vencken, Mieke Kriege, Maartje Hooning, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Progestogenic effects of tibolone on human endometrial cancer cellsL J Blok, P E De Ruiter, E C M Kühne, et al.
Pageof 31